1. Home
  2. FPH vs CERS Comparison

FPH vs CERS Comparison

Compare FPH & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPH
  • CERS
  • Stock Information
  • Founded
  • FPH 2009
  • CERS 1991
  • Country
  • FPH United States
  • CERS United States
  • Employees
  • FPH N/A
  • CERS N/A
  • Industry
  • FPH Real Estate
  • CERS EDP Services
  • Sector
  • FPH Finance
  • CERS Technology
  • Exchange
  • FPH Nasdaq
  • CERS Nasdaq
  • Market Cap
  • FPH 398.9M
  • CERS 347.3M
  • IPO Year
  • FPH 2017
  • CERS 1997
  • Fundamental
  • Price
  • FPH $5.37
  • CERS $1.65
  • Analyst Decision
  • FPH
  • CERS Buy
  • Analyst Count
  • FPH 0
  • CERS 3
  • Target Price
  • FPH N/A
  • CERS $3.17
  • AVG Volume (30 Days)
  • FPH 757.0K
  • CERS 1.5M
  • Earning Date
  • FPH 04-17-2025
  • CERS 02-20-2025
  • Dividend Yield
  • FPH N/A
  • CERS N/A
  • EPS Growth
  • FPH N/A
  • CERS N/A
  • EPS
  • FPH 0.46
  • CERS N/A
  • Revenue
  • FPH $237,926,000.00
  • CERS $180,270,000.00
  • Revenue This Year
  • FPH N/A
  • CERS $15.95
  • Revenue Next Year
  • FPH N/A
  • CERS $10.50
  • P/E Ratio
  • FPH $12.12
  • CERS N/A
  • Revenue Growth
  • FPH 12.37
  • CERS 15.29
  • 52 Week Low
  • FPH $2.83
  • CERS $1.38
  • 52 Week High
  • FPH $6.71
  • CERS $2.59
  • Technical
  • Relative Strength Index (RSI)
  • FPH 48.49
  • CERS 41.40
  • Support Level
  • FPH $5.65
  • CERS $1.64
  • Resistance Level
  • FPH $6.06
  • CERS $1.96
  • Average True Range (ATR)
  • FPH 0.33
  • CERS 0.11
  • MACD
  • FPH -0.14
  • CERS -0.02
  • Stochastic Oscillator
  • FPH 2.03
  • CERS 3.12

About FPH Five Point Holdings LLC

Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational and recreational elements, as well as civic areas, parks, and open spaces. Its four reportable segments are Valencia, San Francisco, Great Park, and Commercial. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: